Molecular Breast Imaging in Clinical Practice
Elizabeth H. Dibble, Katie N. Hunt, Eric C. Ehman, Michael K. O’Connor
Abstract
MBI detects additional cancers compared with conventional imaging in women with dense breasts and those with elevated risk of breast cancer. Its role as an imaging biomarker of cancer risk and in assessing neoadjuvant chemotherapy response is growing. Radiation risk is minimal; benefit-to-risk ratio is similar to that of mammography. MBI is low cost, well tolerated, and easily adapted into clinical practice.
Topics & Concepts
MedicineBreast imagingMedical physicsClinical PracticeMammographyRadiologyBreast cancerFamily medicineInternal medicineCancerBreast Cancer Treatment StudiesBreast Lesions and CarcinomasMedical Imaging Techniques and Applications